Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 2
1960 1
1963 1
1964 5
1965 1
1966 2
1967 4
1969 5
1970 1
1971 2
1972 3
1973 1
1974 12
1975 4
1976 4
1977 7
1978 8
1979 2
1980 4
1981 4
1982 4
1983 5
1984 15
1985 25
1986 18
1987 11
1988 26
1989 29
1990 41
1991 15
1992 27
1993 23
1994 30
1995 40
1996 33
1997 33
1998 28
1999 22
2000 29
2001 31
2002 38
2003 36
2004 15
2005 29
2006 37
2007 40
2008 57
2009 54
2010 67
2011 86
2012 88
2013 79
2014 83
2015 105
2016 107
2017 114
2018 126
2019 128
2020 138
2021 139
2022 145
2023 112
2024 143
2025 119
2026 87
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,476 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA.
Carbone DP, Ciuleanu TE, Cobo M, Schenker M, Zurawski B, Menezes J, Richardet E, Felip E, Cheng Y, Juan-Vidal O, Alexandru A, Mizutani H, Reinmuth N, Lu S, Reck M, John T, Scherpereel A, De Marchi P, Aoyama T, Sathyanarayana P, Grootendorst DJ, Hu N, Ip V, Hung YH, Paz-Ares LG. Carbone DP, et al. Among authors: aoyama t. ESMO Open. 2025 Jun;10(6):105123. doi: 10.1016/j.esmoop.2025.105123. Epub 2025 May 29. ESMO Open. 2025. PMID: 40446626 Free PMC article. Clinical Trial.
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial.
Reck M, Ciuleanu TE, Schenker M, Bordenave S, Cobo M, Juan-Vidal O, Reinmuth N, Richardet E, Felip E, Menezes J, Cheng Y, Mizutani H, Zurawski B, Alexandru A, Carbone DP, Lu S, John T, Aoyama T, Grootendorst DJ, Hu N, Eccles LJ, Paz-Ares LG. Reck M, et al. Among authors: aoyama t. Eur J Cancer. 2024 Nov;211:114296. doi: 10.1016/j.ejca.2024.114296. Epub 2024 Aug 25. Eur J Cancer. 2024. PMID: 39270380 Free article. Clinical Trial.
Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients.
Hashimoto K, Yokokawa T, Nonomiya Y, Shibata N, Soejima A, Kobayashi K, Mae Y, Hasegawa A, Aoyama T, Tateai Y, Ban S, Nigata K, Abe R, Kawakami K, Shimizu H, Ariyasu R, Yanagitani N, Hasegawa K, Kawaguchi T, Yamaguchi M, Suzuki K. Hashimoto K, et al. Among authors: aoyama t. Oncology. 2026;104(2):125-136. doi: 10.1159/000544875. Epub 2025 Mar 10. Oncology. 2026. PMID: 40064150
Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab-Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis.
Peters S, Paz-Ares LG, Reck M, Carbone DP, Brahmer JR, Borghaei H, Lu S, O'Byrne KJ, John T, Ciuleanu TE, Schenker M, Bernabe Caro R, Nishio M, Cobo M, Lee JS, Zurawski B, Pluzanski A, Aoyama T, Tschaika M, Devas V, Grootendorst DJ, Ramalingam SS. Peters S, et al. Among authors: aoyama t. J Thorac Oncol. 2025 Jan;20(1):94-108. doi: 10.1016/j.jtho.2024.09.1439. Epub 2024 Oct 4. J Thorac Oncol. 2025. PMID: 39369790 Free article. Clinical Trial.
Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanced colorectal cancer: a pooled analysis of Japanese clinical trials.
Kawamura H, Honda M, Nakayama Y, Oba K, Muto M, Aoyama T, Kanda M, Maeda H, Mayanagi S, Kashiwabara K, Tanaka K, Sakamoto J, Yamagishi H, Yoshikawa T. Kawamura H, et al. Among authors: aoyama t. Br J Cancer. 2025 Dec;133(11):1660-1667. doi: 10.1038/s41416-025-03199-8. Epub 2025 Sep 22. Br J Cancer. 2025. PMID: 40983629 Free PMC article.
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial.
Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T; J-DOIT3 Study Group. Sasako T, et al. Among authors: aoyama t. JAMA Ophthalmol. 2025 Dec 1;143(12):989-997. doi: 10.1001/jamaophthalmol.2025.3819. JAMA Ophthalmol. 2025. PMID: 41129145 Free PMC article. Clinical Trial.
Adjuvant treatment for esophageal cancer.
Aoyama T, Cho H, Suematsu H. Aoyama T, et al. Surg Today. 2026 Mar;56(3):233-244. doi: 10.1007/s00595-025-03176-x. Epub 2025 Nov 24. Surg Today. 2026. PMID: 41284061 Review.
2,476 results